This result was somewhat surprising in light of our in vitro results; however, the decreased in vivo growth of FGFRL1-KD xenografts could be expected considering the clinical data that indicated increased FGFRL1 in association with tumor growth and progression. Here, FGFRL1 is linked to neoplasm.